Primary hypothesis and study design
cerebral embolisms
CEREBRAL EMBOLISMS
The primary hypothesis of the Embo‐Abl study is that CB ablation is not inferior to RF ablation with respect to the incidence of cerebral embolisms after the CA of AF. The Embo‐Abl study is designed as a prospective, multicenter, open‐label, controlled, randomized, noninferiority clinical study comparing the incidence of periprocedural cerebral embolisms between CB and RF ablation of AF from April 28, 2021 to March 31, 2028 (Figure Flowchart of the study. MRI, magnetic resonance imaging.